Press Releases
F1000Research joins OASPA and COPE, and is listed in DOAJ and SHERPA/RoMEO
11 Jun 2013
F1000Research is delighted to announce the journal's membership of the Open Access Scholarly Publishers Association (OASPA) and the Committee on Publication Ethics (COPE), and its listing in the Directory of Open Access Journals (DOAJ) and the SHERPA/RoMEO directory.
Read more »
Multiple sclerosis: back to basics?
03 Jun 2013
Failure to find an effective therapy for the chronic neurological disease multiple sclerosis (MS), despite 100 years of scientific research, could indicate a fundamental misunderstanding of the nature of the disease, an article published today in F1000Prime Reports http://f1000.com/prime/reports/browse) suggests.
Read more »
F1000Research aims to reduce publication bias
15 May 2013
Open Access life sciences journal, F1000Research, makes a stand to reduce positive bias in the publication record, urging scientists to publish all valid results, including negative and null findings.
Read more »
Use of psychedelic drugs remains prevalent in the United States
23 Apr 2013
An article published in F1000Research, and approved for indexing in PubMed and other major bibliographical databases, estimates that there were approximately 32 million users of psychedelic drugs in the United States in 2010.
Read more »
